Society Letters

Comments on 2022 Medicare Physician Fee Schedule (MPFS) Proposed Rule

September 13, 2021

Dear Administrator Brooks-LaSure:

"On behalf of the Endocrine Society, thank you for the opportunity to provide comments on the Centers for Medicare & Medicaid Services (CMS) Medicare Physician Fee Schedule (MPFS) proposed rule for calendar year (CY) 2022. Founded in 1916, the Endocrine Society represents approximately 18,000 physicians and scientists engaged in the treatment and research of endocrine disorders, such as diabetes, hypertension, infertility, obesity, osteoporosis, endocrine cancers (i.e., thyroid, adrenal, ovarian, pituitary) and thyroid disease. Many of the patients our members treat are Medicare beneficiaries; consequently, the payment policies and other revisions in the MPFS are of importance to our members. We welcome the opportunity to work with CMS to address the ongoing needs of Medicare beneficiaries and ask you to consider our comments on the following sections of the proposed rule as you finalize your policies for CY 2022:

  • Practice Expense Clinical Labor Pricing Update
    Telehealth Services
    Virtual Check-in
    Principal Care Management and Chronic Care Management
    Split (or Shared) Evaluation and Management Visits
    Medicare Diabetes Prevention Program
    MIPS Value Pathways"

arrowRead the Full Letter

Last Updated:
Take Action

Make Your Voice Heard

We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your US representatives or European Members of Parliament through our online platform. Take action and make a difference today.

We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your US representatives or European Members of Parliament through our online platform. Take action and make a difference today.

Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.